Cornerstone Therapeutics Inc. (NASDAQ:CRTX)

CAPS Rating: 4 out of 5

A biopharmaceutical company focused on the development and commercialization of products designed to treat respiratory, inflammatory and critical care diseases linked to the body's inflammatory response.

Recs

0
Player Avatar SmallPimpin (94.30) Submitted: 8/14/2009 5:44:06 PM : Outperform Start Price: $6.59 CRTX Score: -57.80

Mmm...pharmaceuticals...

Featured Broker Partners


Advertisement